Introduction:

Acute otitis media is a bacterial or viral infection of middle ear, which is mainly occurred in people with a cold or allergies. Although, acute otitis media can occur at any stage, it is occurred mainly at ages of 3 months and 3 years. In people with acute otitis media, infected ear is painful, with a red, bulging eardrum. Majority of the acute otitis media infection is resole with antibiotic treatment or home care medications such as application of warm and moist washcloth over infected ear or use of over-the-counter ear drops for the pain relief.

Increasing number of research and development activities by various key players and their underlying clinical trial studies for treatment of acute otitis media will expect show lucrative growth opportunities during forecast period. For instance, Novus Therapeutics, Inc. is a specialty pharmaceutical company engaged in developing the products for patients with disorders of ear, nose, and throat (ENT) is currently in its phase I clinical trials to develop OP-O2. OP-O2 is being developed as a potential treatment option for otitis media (OM). 

The acute otitis media treatment market has been segmented on the basis of drug class, formulation, distribution channel, and region.

On the basis of drug class, the acute otitis media treatment market is segmented into antibiotics, nonsteroidal anti-inflammatory drug, analgesic, and anesthetic.

Formulation segment of acute otitis media treatment market segmented into oral and topical. 

Further, the distribution channel for acute otitis media treatment market includes hospitals, retail pharmacies, and online pharmacies. On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Key players operating in the acute otitis media treatment market includes Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
   • PORTER’s
   • Investment Outlook
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for Acute Otitis Media Treatment Strategies
     • Key Questions this Study will Answer

     • by Drug Class (Antibiotics, Nonsteroidal anti-Inflammatory drug, Analgesic, and Anesthetic)

       by Formulation (Oral and Topical)

       by Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies)

       Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa)

   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Overview
   • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
   • Y-o-Y Growth Analysis (%), 2020 – 2030
   • Regional Trends
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Regional Analysis
   • Regional Revenue Analysis
   • Regional By segment Analysis
   • Reasons for regional growth
   • Key Player of particular region
   • Countries Include in the report:

1. • • North America (U.S., Canada)
     • Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
     • Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
     • Latin America (Brazil, Mexico, Rest of Latin America)
     • Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
   • Competitive Overview
   • Competitive Benchmarking
   • Market Share Analysis
   • Key Developments In The Acute Otitis Media Treatment Market
   • Key Developments: Mergers & Acquisitions
   • Key Developments: Collaboration
   • Key Developments: Contracts & Agreements
   • Key Developments: Expansion
   • Key Developments: Product Developments
2. Company Profiles

 

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Performance
• Business Strategies
• SWOT Analysis

• • Pfizer, Inc.

  • Eli Lilly and Company

  • Abbott Laboratories

  • GlaxoSmithKline plc.

  • Bayer AG

  • Novartis AG

  • Pediapharm Inc.

  • Sanofi S.A.

  • Bristol Myers Squibb Company

1. The Last Word
   • Future Impact
   • About Us
   • Contact